Caruso M, De Keersmaecker K
Philos Trans R Soc Lond B Biol Sci. 2025; 380(1921):20230380.
PMID: 40045783
PMC: 11883432.
DOI: 10.1098/rstb.2023.0380.
Ortmann B
BMJ Oncol. 2025; 3(1):e000154.
PMID: 39886164
PMC: 11203102.
DOI: 10.1136/bmjonc-2023-000154.
Toupenet Marchesi L, Stockholm D, Esteves T, Leblanc M, Auger N, Branchu J
Sci Rep. 2025; 15(1):2370.
PMID: 39827309
PMC: 11743199.
DOI: 10.1038/s41598-025-86337-9.
Wang W, Du Y, Datta S, Fowler J, Sang H, Albadari N
Genes Dis. 2025; 12(2):101156.
PMID: 39802403
PMC: 11719324.
DOI: 10.1016/j.gendis.2023.101156.
Tang J, Moorthy R, Hirsch L, Demir O, Baker Z, Naumann J
Cell Chem Biol. 2025; 32(2):352-362.e10.
PMID: 39778578
PMC: 11848830.
DOI: 10.1016/j.chembiol.2024.12.006.
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or Somatostatinoma.
Wang T, Liu L, Fang J, Jin H, Natarajan S, Sheppard H
Cancer Res. 2024; 85(3):424-441.
PMID: 39531507
PMC: 11786959.
DOI: 10.1158/0008-5472.CAN-24-1142.
Chromosome 8q24 amplification associated with human hepatocellular carcinoma predicts MYC/ZEB1/MIZ1 transcriptional regulation.
Chahine J, Davis S, Culfaci S, Kallakury B, Tuma P
Sci Rep. 2024; 14(1):24488.
PMID: 39424877
PMC: 11489779.
DOI: 10.1038/s41598-024-75219-1.
HSPA12A promotes c-Myc lactylation-mediated proliferation of tubular epithelial cells to facilitate renal functional recovery from kidney ischemia/reperfusion injury.
Li Y, Min X, Zhang X, Cao X, Kong Q, Mao Q
Cell Mol Life Sci. 2024; 81(1):404.
PMID: 39277835
PMC: 11402889.
DOI: 10.1007/s00018-024-05427-5.
Dysfunction of Calcyphosine-Like gene impairs retinal angiogenesis through the MYC axis and is associated with familial exudative vitreoretinopathy.
Liu W, Li S, Yang M, Ma J, Liu L, Fei P
Elife. 2024; 13.
PMID: 39264149
PMC: 11392532.
DOI: 10.7554/eLife.96907.
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.
Przybyszewski O, Mik M, Nowicki M, Kusinski M, Mikolajczyk-Solinska M, Sliwinska A
Biomedicines. 2024; 12(8).
PMID: 39200178
PMC: 11351910.
DOI: 10.3390/biomedicines12081713.
Analysis of the Skin and Brain Transcriptome of Normally Pigmented and Pseudo-Albino Southern Flounder () Juveniles to Study the Molecular Mechanisms of Hypopigmentation and Its Implications for Species Survival in the Natural Environment.
Blandon I, DiBona E, Battenhouse A, Vargas S, Mace C, Seemann F
Int J Mol Sci. 2024; 25(14).
PMID: 39063015
PMC: 11277284.
DOI: 10.3390/ijms25147775.
Suppression of interferon α and γ response by Huwe1-mediated Miz1 degradation promotes SARS-CoV-2 replication.
Arunagiri V, Cooper L, Dong H, Class J, Biswas I, Vahora S
Front Immunol. 2024; 15:1388517.
PMID: 39034993
PMC: 11257858.
DOI: 10.3389/fimmu.2024.1388517.
Circulating non-coding RNA biomarkers of endocrine tumours.
Butz H, Patocs A, Igaz P
Nat Rev Endocrinol. 2024; 20(10):600-614.
PMID: 38886617
DOI: 10.1038/s41574-024-01005-8.
Metastatic extraneural glioblastoma diagnosed with molecular testing.
Majd N, Vo H, Moran C, Weathers S, Song I, Williford G
Oncologist. 2024; 29(9):811-816.
PMID: 38837109
PMC: 11379637.
DOI: 10.1093/oncolo/oyae115.
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer.
Huang C, Hsu C, Chao M, Hsu K, Lin T, Yen S
Protein Sci. 2024; 33(6):e5004.
PMID: 38723164
PMC: 11081522.
DOI: 10.1002/pro.5004.
The immune microenvironment of cancer of the uterine cervix.
Mastrogeorgiou M, Chatzikalil E, Theocharis S, Papoudou-Bai A, Peoch M, Mobarki M
Histol Histopathol. 2024; 39(10):1245-1271.
PMID: 38483012
DOI: 10.14670/HH-18-727.
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.
Venkatraman S, Balasubramanian B, Thuwajit C, Meller J, Tohtong R, Chutipongtanate S
Front Immunol. 2024; 15:1324045.
PMID: 38390324
PMC: 10881682.
DOI: 10.3389/fimmu.2024.1324045.
Overexpression of deubiquitinase (usp 36) in oral squamous cell carcinoma.
Murali P, Kavitha B, Narasimhan M
J Oral Maxillofac Pathol. 2024; 27(4):623-628.
PMID: 38304515
PMC: 10829461.
DOI: 10.4103/jomfp.jomfp_311_23.
USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.
Li M, Yu J, Ju L, Wang Y, Jin W, Zhang R
Cell Death Dis. 2024; 15(1):44.
PMID: 38218970
PMC: 10787741.
DOI: 10.1038/s41419-024-06446-7.
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
Panja S, Truica M, Yu C, Saggurthi V, Craige M, Whitehead K
Nat Commun. 2024; 15(1):352.
PMID: 38191557
PMC: 10774320.
DOI: 10.1038/s41467-024-44686-5.